Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report

Insertions in exon 20 represent the third most common type of EGFR mutation following in-frame deletions in exon 19 and the point mutation L858R in exon 21. They are generally associated with primary resistance to EGFR-TKIs. Although mobocertinib and amivantamab were approved for adult patients with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Xuesong Chen (Author), Wangjian Zha (Author), Mei Su (Author), Nan Meng (Author), Shuliang Cao (Author), Beifang Niu (Author), Xu Qi (Author)
Format: Knjiga
Izdano: Frontiers Media S.A., 2023-02-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto